Geneza Pharmaceuticals GP Phenyl 100 is presented in a 10-milliliter multidose vial and reportedly contains 100 milligrams of nandrolone phenylpropionate per milliliter according to label and/or packaging. Samples of this product were purchased from a European-based internet source between the dates of August 1, 2016 and September 15, 2016.
The samples were forwarded and received by the analytical laboratory SIMEC AG on September 29, 2016. SIMEC performed HPLC-UV quantitative dosage testing, ‘total aerobial microbiological count’ (TAMC) testing and ‘total yeast and mold count’ (TYMC) testing. The report was completed on November 17, 2016.
The “lot number” listed on the product was GP137CN and the expiration date was February 2018. The ISN number “L8T4921U79DP” was successfully used to verify the authenticity of the product on genezapharmaceuticals.com.
Label claim: Geneza Pharmaceuticals GP Phenyl 100 has a label claim of 100 mg/ml nandrolone phenylpropionate.
Actual content: Geneza Pharmaceuticals GP Phenyl 100 was determined to have an actual content of 111.3 mg/ml nandrolone phenylpropionate.
No microbiological contamination was detected.
(The following images are photographs of the actual product that was submitted for testing.)
How many milligrams of nandrolone phenylpropionate are in each milliliter of Geneza Pharma GP Phenyl 100? Is the product free of microbiological contamination? HPLC-UV, TAMC, TYMC (November 17, 2016) ...
|Last Updated||November 19, 2016|